The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Direct-to-Consumer Genetic Testing: Summary of a Workshop
on Environmental Law, he played a key role in organizing international conferences in Europe and Canada on acid rain, and in Mexico City on environmental issues. He was the founding chair of the board of the Center for International Environmental Law, a position he held for 19 years. His book, NEPA in the Courts, went through several printings and was a Literary Guild selection. His book, Environmental Improvementthrough Economic Incentives, has been translated and widely used by governments and in universities. He has written numerous scholarly articles as well as other pieces. Mr. Anderson has served on several National Academies committees, including (1) Board on Atmospheric Sciences and Climate, (2) Commission on Life Sciences, (3) Board on Environmental Studies and Toxicology, (4) Committee on Industrial Competitiveness and Environmental Protection, (5) Committee to Review Risk Management in the DOE’s Environmental Remediation Program, (6) Panel on Integration of Socio-Economic Criteria into the Site Selection Process for a High-Level Radioactive Waste Repository, and (7) Committee on EPA Assessment Factors for Data Quality. He was a member of the National Academies’ planning committee that initiated the 1997 Academy Symposium on Science, Technology, and Law. He has been a member of the Committee on Science, Technology, and Law since its inception.
Barbara E. Bierer, M.D., is Senior Vice President for Research at the Brigham and Women’s Hospital and Professor of Medicine at Harvard Medical School. Dr. Bierer, a graduate of Harvard Medical School, completed her internal medicine residency at the Massachusetts General Hospital and her hematology and medical oncology training at the Brigham and Women’s Hospital and the Dana-Farber Cancer Institute. Dr. Bierer maintained a research laboratory in the Department of Pediatric Oncology at Dana-Farber Cancer Institute and was appointed Director of Pediatric Stem Cell Transplantation at Dana-Farber Cancer Institute and Children’s Hospital in 1993. In 1997, she was named Chief of the Laboratory of Lymphocyte Biology at the National Heart, Lung and Blood Institute at the National Institutes of Health in Bethesda, MD. She served on the Scholars Committee of the Howard Hughes Medical Institute and on the Biomedical Research Training Program for Underrepresented Minorities at NHLBI, where she received the Director’s Award in 1999. She returned to the Dana-Farber Cancer Institute in July 2002 as Vice President of Patient Safety and Director of the Center for Patient Safety. In 2003, Dr. Bierer moved to the Brigham and Women’s Hospital to assume her cur-